456 100% complete response to PEEL-224 in combination with PD-1 blockade in a syngeneic mouse model of colon cancer

• Robert G Maki,
• Joshua D Schiffman,
• Aleah F Caulin,
• Sophia Howard,
• Trent Fowler,
• Ivan Alferiev,
• Michael Chorny,
• Garrett Brodeur,
• Debra Thoma Vallner

Affiliations

Robert G Maki

1Peel Therapeutics, Salt Lake City, UT, USA

Joshua D Schiffman

1Peel Therapeutics, Salt Lake City, UT, USA

Aleah F Caulin

1Peel Therapeutics, Salt Lake City, UT, USA

Sophia Howard

1Peel Therapeutics, Salt Lake City, UT, USA

Trent Fowler

1Peel Therapeutics, Salt Lake City, UT, USA

Ivan Alferiev

2Children’s Hospital of Philadelphia and the University of Pennsylvania/Perelman School of Medicine, Philadelphia, PA, USA

Michael Chorny

2Children’s Hospital of Philadelphia and the University of Pennsylvania/Perelman School of Medicine, Philadelphia, PA, USA

Garrett Brodeur

2Children’s Hospital of Philadelphia and the University of Pennsylvania/Perelman School of Medicine, Philadelphia, PA, USA

Debra Thoma Vallner

1Peel Therapeutics, Salt Lake City, UT, USA